DJE Kapital AG

Position in GILD — Gilead Sciences, Inc.

CIK 1659196 82049 PULLACH, 2M

Position in GILD

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,608,813

-$21,181,248 QoQ

Shares Held

12,734

-92.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#900

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 25% Shared 0% None 75%

Healthcare · as of Jun 30, 2026

DJE Kapital AG holds $622,435,226 across 5 Drug Manufacturers - General names. GILD ranks #5 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	246,220	$295,323,679
2	MRK	Merck & Co., Inc.	1,431,324	$183,925,134
3	JNJ	Johnson & Johnson	510,682	$129,697,907
4	AZN	Astrazeneca PLC	62,650	$11,879,693
5	GILD	Gilead Sciences, Inc. This page	12,734	$1,608,813

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,608,813	12,734	-92.2%	Shares	Sole	2026-08-04
2026-03-31	$22,790,061	163,522	-32.4%	Shares	Sole	2026-05-08
2025-12-31	$29,693,629	241,923	+71.7%	Shares	Sole	2026-02-12
2025-09-30	$15,637,791	140,881	0.0%	Shares	Sole	2025-10-30
2025-06-30	$15,619,476	140,881	+121.7%	Shares	Sole	2025-08-07
2025-03-31	$7,120,329	63,546	—	Shares	Sole	2025-05-09
No filing history on record for this holder in this stock.